Single- and multiple-dose pharmacokinetics of Itraconazole oral solution in healthy men

Japanese Journal of Chemotherapy

Volumn 54, Issue , 2006, Pages 6-17

  Tei, Munetetsu ^a   Yamamoto, Miki ^a   Inoue, Koichi ^b   Torii, Shinichi ^b  

^a KITASATO INSTITUTE   (Japan)

^b Janssen Pharmaceutical KK   (Japan)

Author keywords

hydroxypropyl cyclodextrin; itraconazole; oral solution; pharmacokinetics

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DRUG METABOLITE; ITRACONAZOLE; OMEPRAZOLE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG REEXPOSURE; DRUG SAFETY; DRUG SOLUTION; DRUG STABILITY; DRUG TOLERABILITY; DRUG URINE LEVEL; FOOD DRUG INTERACTION; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; LIVER TOXICITY; MALE; MULTIPLE DRUG DOSE; NAUSEA; NORMAL HUMAN; PRURITUS; SINGLE DRUG DOSE;

EID: 33750590097     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.54.Supplement1_6     Document Type: Article

References (9)

1. Hoestetler J S, Hanson L H, and Stevens D A : Effects of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother 1992; 36 : 477-80
2. Pappas P G, Rex J H, Sobel J D, Filler S G, Dismukes W E, Walsh T J, et. al. : Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38 : 161-89
3. Heykants J, Van Peer A, Van de Velde V, Van Rooy P, Meuldermans W, Lavrijsan K, et. al. : The clinical pharmacokinetics of itraconazole : an overview. Mycoses 1989; 32 : 67-87
4. Van de Velde V J S, Van Peer A P, Heykants J J P, Woestenborghs R J, Van Rooy P, De Beule K L, et. al. : Effect of food on the pharmacokinetics of a new hydroxypropyl-β-cyclodextrin formulation of Itraconazole. Pharmacotherapy 1996; 16 : 424-8
5. Prentice A G and Donnelly P : Oral antifungals as prophylaxis in haematological malignancy. Blood Reviews 2001; 15 : 1-8
6. Willems L, Van der Geet R, and de Beule K : Itraconazole oral solution and intravenous formulations : a review of pharmacokinetics and pharmacodynamics. J Clin Pharm Ther 2001; 26 : 159-69
7. Rex J H, Pfaller M A, Galgiani J N, Bartlett M S, Espinal-Ingroff A, Ghannoum M A, et. al. : Development of interpretive breakpoints for antifungal susceptibility testing : conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clinical Infections Diseases 1997; 24 : 235-47
8. Stevens D A : Itraconazole in cyclodextrin solution. Pharmacotherapy 1999; 19 : 603-11
9. Levron J C, Le Moing J P, Chewetzoff E, Groen K : Study of the effect of omeprazole on the bioavailability of a single administration of itraconazole oral solution. (clinical research report) unpublished 1996